Narinder Bhalla

Equibles does not estimate personal net worth.

About Narinder Bhalla

Lexeo Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lexeo Therapeutics, Inc. includes R. Nolan Townsend (CEO and Board Member), Kyle Rasbach (CFO and Chief Accounting Officer), Louis Tamayo (CFO) and 7 others.

Affiliation history

Lexeo Therapeutics, Inc. (LXEO)
Proxy statement

Current
Start not stated–present

Last confirmed April 30, 2026

Company network

Lexeo Therapeutics, Inc.

LXEO

Current role

Biotechnology · Healthcare

Leadership on record at Lexeo Therapeutics, Inc.

R. Nolan Townsend CEO, Board Member
Kyle Rasbach CFO, Chief Accounting Officer
Louis Tamayo CFO
Jose Manuel Otero COO
Jose Manuel Otero, Ph.D. COO
Brenda Cooperstone Board Member
Continuing Directors Board Member
Dr. Laura Sepp-Lorenzino Board Member
Laura Sepp-Lorenzino Board Member
Mette Kirstine Agger Board Member

Recent activity

No call appearances or filed executive changes recorded yet.